background: The endosymbiosis of an alpha-proteobacterium and a eubacterium a billion years ago paved the way for multicellularity and enabled eukaryotes to flourish. The selective advantage for the host was the acquired ability to generate large amounts of intracellular hydrogendependent adenosine triphosphate. The price was increased reactive oxygen species (ROS) inside the eukaryotic cell, causing high mutation rates of the mitochondrial DNA (mtDNA). According to the Muller's ratchet theory, this accumulation of mutations in asexually transmitted mtDNA would ultimately lead to reduced reproductive fitness and eventually extinction. However, mitochondria have persisted over the course of evolution, initially due to a rapid, extreme evolutionary reduction of the mtDNA content. After the phylogenetic divergence of eukaryotes into animals, fungi and plants, differences in evolution of the mtDNA occurred with different adaptations for coping with the mutation burden within these clades. As a result, mitochondrial evolutionary mechanisms have had a profound effect on human adaptation, fertility, healthy reproduction, mtDNA disease manifestation and transmission and ageing. An understanding of these mechanisms might elucidate novel approaches for treatment and prevention of mtDNA disease.
Introduction
Mitochondria are fundamental to the origin of (multicellular) eukaryotes and provide the eukaryotes with the capability of generating energy, at the cost of high mutagenesis, partially due to the production of reactive oxygen species (ROS). It is this high mutation rate that has had a profound impact on the composition and inheritance of the genetic material within the mitochondria: the mitochondrial DNA (mtDNA). This mtDNA is indispensable for oxidative phosphorylation (OXPHOS), the process of aerobic adenosine triphosphate (ATP) production in the mitochondria as it encodes part of the OXPHOS proteins (Fig. 1) . The remainder of the mitochondrial proteins are encoded by the nucleus and are imported into the mitochondria. The presence of ROS can lead to mutation rates which, in combination with uniparental, asexual inheritance, would eventually have led to disappearance of the mtDNA according to Muller's ratchet, but obviously that has not occurred. Eukaryotes have developed a variety of strategies to prevent fixation of mtDNA mutations. Although beneficial at the level of the species, these evolutionary mechanisms can have adverse effects at the level of the individual. The driving forces and underlying mechanisms of mitochondrial evolution across eukaryotes most likely explain how human mtDNA disease and mtDNA-related fertility problems arise and are being transmitted, and also reveal what approaches could be undertaken for treatment and/or prevention.
Search methods
The scientific literature was searched using PubMed for studies associated with mtDNA evolution, mtDNA inheritance and mtDNA characteristics with a focus on animals, plants and fungi. This search resulted in an overview on how mtDNA evolved from its origin to its current characteristics. These characteristics were used as novel search terms such as ROS, Muller's ratchet, mtDNA recombination, mtDNA inheritance, mtDNA bottleneck and mtDNA purifying selection in relation to mtDNA mutation rates. From these mechanisms, we studied the consequences that individuals suffer from these evolutionary mechanisms by searching literature for mtDNA disease, mtDNA adaptation and mtDNA and fertility. From these three separate searches, we elucidated the relevant characteristics, evolutionary mechanisms and consequences that the evolution of the mtDNA has on human health and fertility.
Mitochondria: function, origin and evolution

Mitochondrial metabolism and OXPHOS
Mitochondria are powerhouses producing the majority of cellular energy (ATP) inside the mitochondrial double membrane. The number of mitochondria within a cell can vary depending on the energy demand of the specific cell type. Although energy production is the main function of mitochondria, other cellular processes, such as heme synthesis, cellular apoptosis and calcium homeostasis, are also carried out by mitochondria.
Aerobic generation of energy is a multistep process ending with OXPHOS ( Fig. 1 ). NADH and FADH 2 drive the OXPHOS system which is embedded in the mitochondrial inner-membrane and which consists of five enzyme complexes (I -V) and two electron carriers: co-enzyme Q and cytochrome c (Fig. 1 ). NADH and FADH 2 donate electrons to and thereby reduce complex I (NADH) or complex II (FADH 2 ) which are re-oxidized by the electron carrier co-enzyme Q. The chain of oxidation and reduction events and electron transfer is continued through complex III, electron carrier cytochrome c and complex IV. The energy released during this process is used by complex I, III and IV, but not II, to transport protons (H + ) from the mitochondrial matrix into the inter-membrane space. Finally, these protons flow back across the membrane through complex V, leading to the production of ATP out of ADP and inorganic phosphate (Pi). The ATP is transported out of the mitochondrial matrix into the cytosol by the adenine-nucleotide transporter (ANT1) (Neckelmann et al., 1987) , where it can be used as an energy source (Fig. 1 ). The process of OXPHOS is well-conserved, especially the core subunits Huynen, 2003, 2004) , although some species lack complex I, e.g. most yeast (Baile and Claypool, 2013) .
Evolution of mitochondria
Originally, mitochondria were free-living prokaryotes but more than a billion years ago an endosymbiotic event made the free-living bacterium part of what became a eukaryotic cell (Lane and Martin, 2010) . It is unknown whether the symbiosis was immediately beneficial for the host. According to a recent theory, the mitochondrion originated from an obligate intracellular bacterium that parasitized on the energetic capabilities of its host due to its moderate OXPHOS capacity (Wang and Wu, 2014) . However, during evolution mitochondria changed from being a parasite into a central mutualistic organelle. It has long been thought that the benefit for the anaerobic host, an amitochondrial eukaryote (or archezoan), was the acquired ability to detoxify oxygen (Embley, 2006) ; this hypothesis is known as the archezoan theory (Koonin, 2010) . However, the absence of amitochondrial eukaryotes (Embley and Hirt, 1998) and early phylogenetic studies suggest that the archezoan theory is incorrect. Eukaryotic starlike-trees exist, composed of a few large hypothetical eukaryotic subgroups, each consisting of primarily microbial eukaryotes that radiated at the same time (Keeling et al., 2005) . This fits with an alternative hypothesis, the symbiogenesis theory (Koonin, 2010) , which, although the mechanism of endosymbiosis is unclear, suggests a prokaryotic rather than a eukaryotic host. Instead of detoxification of oxygen, hydrogen-dependent ATP production was the eventual fundamental force for the symbiotic association between an anaerobic (hydrogen-dependent) archaebacterium (the host) and a respiring, facultative anaerobic eubacterium (the symbiont) that generated hydrogen as waste product (Martin and Muller, 1998) . The symbiogenesis theory is revolutionary, since it further implies that eukaryotes evolved integral, instead of prior, to mitochondrial endosymbiosis, as was generally accepted within the archezoan theory. The symbiogenesis theory also explains the ubiquitous and diverse nature of mitochondrial organelles (Embley, 2006; Hampl et al., 2008) . The divergence of anaerobic mitochondria and mitochondria-related organelles, in combination with the widely accepted view that the symbiotic event occurred only once (since all known eukaryotic groups contain a preserved set of homologous genes in their mtDNA), can only be explained if the mitochondrial host was of anaerobic prokaryotic origin (Embley, 2006) .
Regardless of the founding theory, it is therefore without doubt that the mitochondrion itself is of prokaryotic origin. Prokaryotes lack a nucleus and organelles and their genetic material is soluble and located in the volume created by the cell membrane. Although the exact mitochondrial ancestor is unknown, a recent phylogenetic study has assigned this proto-mitochondrion to the class of alphaproteobacteria (Ferla et al., 2013) . Mitochondria are small compared with their alpha-bacterial ancestors and the Rickettsia species seems to be the closest relatives of mitochondria, with a genome of 1 Mb (Table I) , containing all the homologous genes needed for OXPHOS (Muller and Martin, 1999) . well as pyruvate, which can be transformed into acetyl-CoA. Fatty acids (FAs) are biochemically dissimilated by mitochondrial beta-oxidation, which also results in acetyl-CoA. This acetyl-CoA is the substrate for the Krebs cycle, where the acetyl-group is donated to oxaloacetate, generating citric acid, which is dissimilated stepwise during the Krebs cycle resulting in ATP generation and production of the reducing agent NADH. NADH is also produced during the beta-oxidation along with FADH 2 , another reducing agent. These reducing agents drive the process of ATP production by OXPHOS. ROS are produced as by-products of the OXPHOS and can damage the mtDNA.
Evolutionary role of mtDNA in fertility and disease
Animal, plant and fungal mitochondrial genomes
The mitochondrial genomes of animals, plants and fungi (Table I ) display a strong reduction in gene number and genome size during evolution. Most of these changes occurred between the bacterial ancestor and the Last Eukaryotic Common Ancestor (LECA) and are the result of both losses of alpha-proteobacterial genes, alongside with endosymbiotic gene transfer (EGT) from the alpha-proteobacterial DNA to the nucleus. The net result is that mainly genes encoding proteins involved in energy metabolism and translation are maintained (Huynen et al., 2013) , at the expense of, for example, genes for repair and recombination of DNA. Although most of these changes occurred very early during mitochondrial evolution, before the radiation of eukaryotes, subtle proteome evolution still occurs (Huynen et al., 2013) and, basically, the mtDNA is unique for each species and tailored for its specific nuclear background. As a result, mitochondria are not functional across species (further discussed under 'Human mitochondrial diseases').
The mtDNA has a genetic code, which differs from the genetic code in the nucleus [NCBI: http://www.ncbi.nlm.nih.gov/Taxonomy/Utils/ wprintgc.cgi (5 May 2015, date last accessed)]. These differences arose during evolution after endosymbiosis. For example, in metazoan mitochondria the UGA codon is allocated to Tryptophan, while it serves a stop codon in the nucleus, indicating that this codon reassignment has occurred within a common ancestor of Metazoa. Likewise, the AGN, AUN and AAN codons changed during metazoan evolution. The characteristics of the transfer RNAs (tRNAs) restrict the manner in which codes can change (Yokobori et al., 2001) and it seems that EGT continued until, although roughly estimated, the UGA codon was switched from a stop codon to amino acid coding in the animal and fungal line (Leblanc et al., 1997; de Grey, 2005) . A number of proteins from alphaproteobacterial origin were lost and replaced by host proteins as part of the process of non-orthologous gene displacement (Koonin et al., 1996) , giving some species special types of proteins that are absent in others, depending on when and how the event occurred during evolution. Anderson et al. (2001) Crucial in the development of mitochondria as intracellular organelles was the acquisition of a system to import proteins from the cytosol into the mitochondria (Timmis et al., 2004) . This system facilitated both expansion of the mitochondrial proteome and mtDNA genome reduction, since nuclear-encoded proteins can be imported into the mitochondria (Gabaldon and Huynen, 2004) . Acquisition of the ATP/ADP transporter to release mitochondrial-produced ATP into the cytosol gave the mitochondria their crucial position as powerhouses (Amiri et al., 2003) . Together, gene loss, replacement, transfer and acquisition have made modern mitochondria separate from their alpha-proteobacterial ancestors.
Animals
Animal mitochondrial genomes have some important unique characteristics. First, the mtDNA underwent the most extensive genome reduction, resulting in a compact genome, ranging from 13 764 bp in Caenorhabditis elegans to 17 553 bp in Xenopus laevis (Table I) , with only 14-16% of the proto-mitochondrial (alpha-bacterial) proteome still present (Gabaldon and Huynen, 2003) . Some structural OXPHOS subunits and the necessary protein synthesis genes remained in the mtDNA in higher animals, whereas the other genes were either transferred to the nucleus or lost due to the presence of genes with similar function in the nuclear genome (Adams and Palmer, 2003) . In almost all animal species, including humans, the mtDNA contains only 37 genes, of which 13 are protein-coding genes, 2 encode ribosomal RNAs (rRNA) and 22 encode tRNAs (Boore, 1999;  Table I ). Since tRNAs cannot be imported from the cytosol into the mitochondria, the tRNAs needed to translate the (different) genetic code are encoded by the mtDNA itself (Yokobori et al., 2001) . Secondly, animal mitochondrial genomes contain no introns and few repeat sequences (Boore, 1999) . As a result, animal mtDNAs show only limited signs of recombination (Barr et al., 2005) . Thirdly, animals maintain a high mtDNA copy number (Table II) . A cell can contain over 500-1000 mtDNA molecules, depending on the energy demand of a cell (Smeets, 2013) . In oocytes, the mtDNA copy number is highest, ranging from 100 000 to 14 000 000 copies. A fourth feature of animal mitochondrial genomes is its exclusive maternal inheritance, as sperm mitochondria are actively degraded (Cummins, 1998) by proteasomal (ubiquitin) and lysosomal (mitophagy) degradation pathways, during which ubiquitin-binding receptors might serve as mitophagy receptors; this mechanism is most likely prevalent among the animal taxa (extensively reviewed in Sato and Sato, 2013; Song et al., 2014) . Finally, gene replacement and transfer have led to several genes being unique to the animals (Metazoa) or to animals and fungi (Opisthokonta) (see Table I from Huynen et al., 2013) , an important one being the nuclear-encoded DNA polymerase gamma genes (POLG and POLG2), which have replaced the bacterial genes dnaN, dnaE en dnaQ. POLG is the only polymerase found in mammalian mitochondria and is of viral origin due to gene exchange (Filee et al., 2002) .
Plants
Plant mitochondria differ from their animal counterparts in a number of ways. First, genome reduction was less pronounced and more variable in the plant mtDNA, which can contain over 100 genes (Unseld et al., 1997) . In addition, several genes that were transferred during animal evolution are retained in plant species, like the complex II genes sdh3 and sdh4 (Unseld et al., 1997; Turmel et al., 2002) . Especially the mtDNA size of land plants differs from animal mtDNA, ranging, on average, from 180 to 370 kb, with some extreme exceptions (Table I) . Noncoding DNA was inserted in the mtDNA after the evolutionary branching of the land plants, since the common ancestor was gene-rich and contained little introns (Turmel et al., 2003) and this resulted in the presence of repeated segments, introns, intronic Open Reading Frames and incorporated foreign DNA of plastid, nuclear or plasmid origin (Unseld et al., 1997; Bullerwell and Gray, 2004) . With all these features, the mtDNA genomes of plants resemble, unlike their animal counterparts, the size-relaxed nature of a nuclear genome, including recombination events, which give plants the ability to possess sub-genomic molecules variable in size (Preuten et al., 2010) . Therefore, no universal mtDNA copy number exists in plants, but there are differential gene copy numbers, as assessed by four mitochondrial genes that differ in their copy number from each other and among tissues in the Arabidopsis species (Preuten et al., 2010) . Similar to animals, the predominant mode of mitochondrial inheritance is maternal (Barr et al., 2005) , governed by a variety of mechanisms, including methylation and/or zygotespecific gene expression .
Important for plants is the presence of another endosymbiont, the chloroplasts. Its key function, photosynthesis, generates carbohydrates and ATP from sunlight and water, which is the main energy source for chloroplast-containing organisms, whereas mitochondria are the main energy source (due to respiration) for organisms without chloroplast. (Moller, 2001; Jacoby et al., 2012) . Finally, in plants the nuclear-encoded MSH1 gene is a unique property of the species, since it is the result of the fusion between a bacterial DNA-repair homologue of MutS and an endonuclease. It seems that this gene has enabled plants to have recombination-mediated repair of the mtDNA (Abdelnoor et al., 2006) . As in animals, acquisition of genes can be restricted to the clade of plants.
Fungi
Animal and plant mitochondria have been studied extensively, whereas their fungal counterparts are much less-well described. Although fungi are evolutionary more close to animals than plants, their mtDNA contains many plant characteristics. The presence of introns, which can be up to 5 kb in length (Lang et al., 2007) , explains the differential size seen in fungal mtDNA, which ranges on average from 20 to 100 kb, with some large exceptions ( Table I ). The appearance of repetitive elements in introns gives fungal mtDNAs their recombination capabilities (Lang et al., 2007) , which partly explains the enormous variation in gene order among fungal mtDNAs (Lang et al., 2007; Aguileta et al., 2014; Himmelstrand et al., 2014) . It is not clear whether fungi have a mtDNA copy number comparable to animals. However, since recombination is present, it is expected that their copy number can be regulated in a similar fashion as in plants and that sub-genomic mtDNA molecules will exist. Fungi are less complex eukaryotes with no strict energy requirements and, although they contain no chloroplasts, fungi are not as dependent on carbohydrates and lipids as animals. Instead, fungi display a high degree of versatility in their metabolic demands and also use different organic substrates, which can be as simple as nitrate or ethanol. Fungi are scavengers and feed on nutrient molecules from others and secrete digestive enzymes to the exterior to digest any nutrient that is available. The net result is that fungi are less dependent on mitochondria than are animals, but more dependent than are plants due to the absence of chloroplasts. The mtDNA inheritance of fungal mitochondria is complex, with no universal mechanism of inheritance, allowing both uniparental and biparental inheritance (Barr et al., 2005) . In yeast, an almost equal contribution of mitochondria from both parents contributes to the zygote (Birky, 1995) . Some fungi have biparental inheritance of mitochondrial plasmids (small extragenomic mtDNA molecules) that retain parental mtDNAs (Yang and Griffiths, 1993) . Fungal mitochondria are considered as somewhere in between the evolution of plant and animal mitochondria.
Summary
Although most mtDNA changes appear to have taken place before the radiation of the eukaryotes, the evolutionary paths of mtDNA among the main eukaryotic clades could not differ more (Table II) . In the next part of this review, we will focus on how these differences have evolved and what the impact is on mitochondrial biology for humans in health and disease.
Evolutionary mechanisms in mitochondria
Mutations in the mtDNA: Muller's ratchet and mutational meltdown Asexual populations accumulate detrimental mutations according to Muller's ratchet (Muller, 1964; Allen et al., 2009; Goyal et al., 2012) , because the accumulation is irreversible due to the absence of mutation-recovering mechanisms, such as sexual reproduction and recombination-mediated repair, eventually decreasing the fitness of a population (Lynch, 1996 , Lynch et al., 2006 Rand, 2008; Goyal et al., 2012) . Extensive modelling (Gessler, 1995) and laboratory experiments provide evidence for the existence of Muller's ratchet and its potential for decreasing fitness by a mutational meltdown (Goyal et al., 2012 ). Muller's ratchet explains, for example, the high incidences of non-synonymous mutations in Caenorhabditis briggsae (Howe and Denver, 2008) and the degeneration of the neo-Y chromosome in Drosophila miranda (Kaiser and Charlesworth, 2010) . Such degeneration has also been discussed for the mammalian Y chromosome (Bachtrog, 2008 ).
Muller's ratchet in mtDNA
The mtDNA is an asexual population, being inherited maternally in animals and plants, making this genome also prone to the detrimental consequences of Muller's ratchet. Following the path of evolution, the endosymbiosis of the mitochondria allowed an increased level of cellular energy and the expression of a substantially larger number of proteins in eukaryotes than in prokaryotes (Lane and Martin, 2010; Gray, 2012) . This increased energy is produced by OXPHOS, during which electrons leak to O 2 and produce ROS, like superoxide (Brand, 2010) . This ROS toxicity arose simultaneously with the symbiosis event and the integration of metabolic pathways even enhanced the ROS production, that originally served as a cellular response at the outskirts of the (possibly parasitic) bacterium (Speijer, 2014) , also observed during plant-pathogen interactions (de Gara et al., 2003) and in infected HeLa cells (Boncompain et al., 2010) . While unicellular eukaryotes have low energy consumption and subsequent less ROS production, the symbiosis event and the development of multicellularity brought the ROS-producing endosymbiont inside the eukaryotic cells, exposing the newborn eukaryotic (multicellular) organisms to a high and detrimental ROS-induced mutagenesis level. This increased mutation pressure, in combination with the limited action of recombination, e.g. in mice (Hagstrom et al., 2014) and humans (Elson et al., 2001a) , implies an increased vulnerability of mtDNA to a mutational meltdown. Indeed, in mammals, the mutation rate in mitochondria is much higher than in the (recombining) nucleus (Lynch et al., 2006 ). Muller's ratchet in mitochondria has been quantified (Loewe, 2006) and molecular proof exists for the process in mitochondrial tRNAs, which accumulate mutations more rapidly compared with their nuclear counterparts (Lynch, 1996) . If Muller's ratchet could not be counteracted, the inevitable consequence of its genomic decay is extinction of species. However, mtDNA and eukaryotes are still present today, suggesting solutions for preventing detrimental mutation accumulation and subsequent declines in reproductive fitness, which, in the context of mtDNA, are specific mechanisms.
Mitochondrial evolutionary mechanisms to balance high mutation loads
One of the parameters determining the rate of mutation-related decline in fitness is the rate at which these mutations are introduced. In animals, this mutation rate is much higher (up to 100× in mammals) compared with that in plants. In mammalian mitochondria, the mutation rate is 25× higher than in the nucleus, whereas in plants this difference is much lower (Lynch et al., 2006) . Fungal mutation rates are more similar to plants. A higher mutation rate in the mtDNA in animals might reflect a higher adaptive capacity to balance mitochondrial energy and heat requirements with respect to the environment (Wallace, 2007) . Plants lack this adaptive need, since they typically live in restricted ecological niches, can rely on both mitochondria and chloroplasts for their energetic needs and they can survive as seeds, which animals cannot. Fungi share this feature of plants by the production of spores and are also less dependent on mitochondria due to their metabolic versatility. A higher mutational rate will generate mutations of any type, meaning that higher adaptive capacities are at the cost of a higher detrimental mutation load and a higher risk for mutation accumulation.
Several mechanisms have evolved to prohibit mutation accumulation: mutation prevention, diluting the chance of acquiring mutations and recovery of mutations (Table III) . Where EGT was an effective general mechanism to lower mutation accumulative effects, species-specific mechanisms also exist, underlying differences in mutation rates, as well as differences in the mtDNA composition among species.
Mutation prevention: EGT and antioxidants
As mentioned above, a general way to avoid mutation accumulation is moving the mtDNA genes to the nucleus, which is achieved by EGT, which had already occurred in the LECA. Changes in the mtDNA genome from this point resulted in the specific characteristics of modern mitochondria in different species. The early evolutionary pressure was likely to be very high, since EGT occurred at high rates in all eukaryotic species (Blanchard and Lynch, 2000) , despite being very complex and involving, for example, acquisition of a transitpeptide to re-access the mitochondrion. This is corroborated by the fission of several mitochondrial proteins, indicating that even the transfer of only a small part of a gene is favoured, as illustrated for the hydrophilic c-terminal portion of cytochrome c oxidase subunit 1 gene (COX1; a subunit of complex IV) (Gawryluk and Gray, 2010) . It is conceivable that gene redundancy together with mitochondrial ROSmediated high mutation rates drives EGT. Since the nucleus is less prone to mutations, because of its protection by histones and extensive repair and recombination, EGT is a successful tool to reduce mutation loads. The higher degree of EGT observed in animals, might therefore be a reflection of the higher mutation rate of animal mitochondria. However, EGT was not completed and mtDNA has remained in all species, most likely for biochemical reasons (the combination of extreme hydrophobicity of the mtDNA-encoded proteins, precluded easy import in the mitochondria) and the introduction of differences in the genetic code (as with the UGA codon) (de Grey, 2005) . Mutation accumulation risk might not be the only evolutionary force that contributed to EGT. Selection of small organellar genomes might also be involved, having a replicative advantage, as the mtDNA size is linked to the time and energy needed to complete mitochondrial duplication (Berg and Kurland, 2000) , and the level of metabolic efficiency (Selosse et al., 2001) .
The evolutionary role of ROS is obvious from the evolvement of additional eukaryotic mitochondrial capabilities to mitigate the disadvantages of ROS production. These include (1) the peroxisomal breakdown of fatty acids (FAs) which normally render a lot of ROS, (2) the uncoupling of protons without the formation of ATP and ROS, (3) a shuttle that ensures high concentrations of the antioxidant carnitine and (4) the breakdown of dysfunctional ROS-producing mitochondria by mitophagy-mediated mitochondrial quality control (Kurihara et al., 2012; Speijer, 2014; Speijer et al., 2014) . Mutation rates introduced by ROS can be further lowered by the presence of antioxidants. Especially in plants and fungi, these systems, such as the AOX-system during stress conditions in plants, are up-regulated so that they scavenge most of the ROS that is produced.
Diluting the target: high copy number or introduction of non-coding DNA Plants and fungi have incorporated stretches of DNA that allow recombination-mediated mtDNA repair (a feature that is almost absent in animals) so protein-coding parts are less likely affected. Animals achieve this by maintaining a multi-copy genome (typically . 500 copies/animal cell). A high copy number ensures that not all genes can be affected by a mutation at the same time, leaving fully functional sets of proteins always present. Mammalian mtDNA copy numbers are highest in oocytes, typically above 100 000 copies, but vary among (Table IV) . There seem to be three classes: in the first class, represented by humans, mice and rats, oocytes can have an mtDNA copy number between 100 000 and 200 000 copies, although some outliers are found. Secondly, for example in bovines, sheep and pigs, the mtDNA counts of oocytes are typically above 300 000, but below 1 000 000 copies. The final class, represented by salmon and zebrafish, have the highest mtDNA copy numbers of several million genomes. An explanation for this variation might be the different implantation patterns among the species or even the lack of implantation. Implantation has been classified into three categories: centric, eccentric and interstitial (Wimsatt, 1975) , based on the different types of interactions between blastocysts and uterine cells. Centric implantation is characterized by a large expansion of the blastocyst before implantation, followed by fusion with the luminal epithelium (Lee and DeMayo, 2004) . Bovines, sheep and pigs have this type of implantation. Mice and rats, on the other hand, have an eccentric implantation pattern, where the luminal epithelium forms an invagination to surround the trophoblast. The human implantation pattern is interstitial as the trophoblast passes through the luminal epithelium to invade the endometrial stromal and become imbedded into the wall of the uterus (Wimsatt, 1975) . A fourth group consisting of, for example, salmon and zebrafish, has no implantation at all. Another factor can be the speed at which implantation occurs. Rats, mice and humans have an immediate, fast implantation, with immediate access to high levels of nutrients within the female reproductive tract that can be utilized by the embryo (Leese, 2002) , whereas at the other end of the spectrum, as in salmon and zebrafish, implantation is absent. The class with bovines, sheep and pigs is in between with a more delayed implantation. A high copy number in oocytes is needed to distribute mtDNA molecules over the daughter cells in the absence of mtDNA replication during early embryogenesis (May-Panloup et al., 2005b; Thundathil et al., 2005) and the differences in copy number between species could be, although speculative, a reflection of different energetic needs during early development in animals. These energy needs range depending on whether there is a rapid direct access to the maternal blood supply, as in humans (lowest mtDNA copy number), delayed access (intermediate mtDNA copy number) or a complete dependence on their own energy storage from the yolk-sac during the whole of embryogenesis (Wolff and Gemmell, 2008) , as in fish (highest mtDNA copy number). The longer implantation is delayed, the higher the energy demand is for the preimplantation embryo, being most extreme when implantation is completely absent (as in most cold-blooded species).
Mutation recovery: recombination-mediated repair
The last class of evolutionary mechanisms aims to remove or repair mtDNA mutations. For this, plant mtDNA undergoes recombination, mediated by repeat sequences, whereas animal mtDNA does not or has only limited recombination. Repeat sequences cause ectopic recombination, a potential harmful feature that can disrupt coding frames and gene expression, generating an additional selective pressure for efficient mtDNA repair. For this repair, plants harbour a unique fusion-product: the nuclear-encoded MSH1 gene (Abdelnoor et al., 2006) . In Arabidopsis, the MSH1 gene allows plants to have an efficient recombinationmediated mismatch repair and gene conversion, which reduces heteroplasmy (Davila et al., 2011) and is driven by the presence of repeat sequences (Galtier, 2011) . Fungal MSH1 genes are homologues of the MutS gene, but do not possess the endonuclease domain and have been reported not to be involved in mismatch repair in yeast (Sia and Kirkpatrick, 2005) . Although fungi display recombination due to accumulated repeats and introns, resulting in a high variability in the mitochondrial gene order, their mutation rate is intermediate between animals and plants (Lynch et al., 2006; Aguileta et al., 2014) . Recombinationmediated mtDNA repair in plants and some fungi can also occur via other mechanisms (see Ricchetti et al., 1999) and is a perfect tool for lowering the ROS-generated mutational burden (further discussed in: Marechal and Brisson, 2010; Christensen, 2013 Mutation recovery: the mtDNA bottleneck
During the cleavage stages of embryogenesis, the total amount of mtDNA is constant, indicating a random partitioning of the mtDNA over the different daughter cells Cree et al., 2008) and only those cells that develop into an embryo will contribute to the mtDNA pool of the newborn embryo, leading to a strong numerical bottleneck (Bergstrom and Pritchard, 1998) . In 1989, such a bottleneck for mtDNA inheritance was first observed in Holstein cows, resulting in rapid fixation of heteroplasmic variants during transmission to following generations and a return to homoplasmy (Ashley et al., 1989) ; this implies a sampling effect of mtDNA molecules early during embryogenesis. A restriction in the number of mtDNA molecules to be transmitted to the next generation is followed by a strong amplification of these founder molecules. During oogenesis in mice, a 100-fold increase in the mtDNA amount has been observed, without any further increase during preimplantation development (Piko and Taylor, 1987) . The sampling effect and random genetic drift, during the formation of primordial germ cells (PGCs) and oocyte maturation (clonal expansion) determine the mtDNA that is inherited. The net result is a reset to homoplasmy within a very short time-frame in which germ cell mtDNA is most sensitive to mutagenesis. Besides the observations in mammals and rodents, the mtDNA bottleneck has been described in Chinook salmon (Wolff et al., 2011) and Danio rerio (Otten et al., in preparation). These two teleost species are non-mammalian vertebrates and both show an mtDNA bottleneck that is remarkably similar to the one documented in mice. This indicates that, within the clade of Metazoa or at least the Vertebrata, the mtDNA bottleneck is a highly conserved mechanism. The mtDNA copy number is brought back to 200 in germ cells, which seems quite conserved in humans, mice (Cree et al., 2008; Wai et al., 2008) , salmon (Wolff et al., 2011) and zebrafish (Otten et al., in preparation). Apparently, this amount of mtDNA protects the species from pre-existing mutation accumulation due to rapid segregation (Guo et al., 2013) , while preserving fertility, resulting in a low vulnerability for de novo mutations to reach significant heteroplasmy levels (as discussed below).
Mutation recovery: bottleneck-mediated selection
Mutations that escape the mtDNA bottleneck can be filtered out by purifying selection at the level of the organelle in animals during early embryonic development (Bergstrom and Pritchard, 1998; Stewart et al., 2008a, b) . Purifying selection can take place either by positive or negative selection on mtDNA sequences and evidence exists for both processes (Bazin et al., 2006; Meiklejohn et al., 2007) . In the mutator mouse, mutations accumulate at random in the mtDNA and purifying selection has been detected by the analysis of mutation distribution after backcrossing. Potential deleterious mutations are strongly underrepresented, implying selection against these mutations in the mammalian germ line (Stewart et al., 2008a, b) . Furthermore, in transmitochondrial mice, a severe OXPHOS-affecting mutation is eliminated rapidly from the maternal germ line (Fan et al., 2008) , further proving the existence of purifying selection. The exact mechanism of purifying selection at the level of the organelle is unknown, but is thought to be achieved by functional testing of mtDNA at the single organelle level, most likely near or at the bottom of the bottleneck. A number of mechanisms have been proposed . The absence of mtDNA replication during early embryogenesis (Ebert et al., 1988) leads to a very low mtDNA count in the PGCs. Most likely, this is a prerequisite to selectively filter out deleterious mtDNA mutations, since it is only when the mtDNA load is small, that differences in organelle fitness can manifest quickly and be selected for (Wai et al., 2010) . Another possible mechanism of purifying selection has been postulated for Drosophila melanogaster , based on selective replication of wild-type mtDNA molecules with a more robust OXPHOS capacity; this hypothesis is enforced by the observation that selective replication of functional mtDNA molecules is able to restrict the transmission of deleterious mtDNA variants and that the replicative advantage is coupled to mitochondrial fitness (Hill et al., 2014) . The exact nature of this replicative advantage is not known, but could be achieved by the energy demanding burst of mtDNA replication during oogenesis, allowing selection for mtDNA with an efficient energy production, thus favouring their replication. Finally, mtDNA correction based on fusion and fission of mitochondria could be implicated in purifying selection, leading to selective breakdown (mitophagy) of damaged mitochondria (Twig et al., 2008) ; this process is thought to be regulated by Parkin (Glauser et al., 2011) . However, purifying selection seems to occur independently of Parkin in D. Melanogaster .
Summary
As shown in Table III and Fig. 2 , animals, plants and fungi have, besides EGT, different species-specific mechanisms to ensure mitochondrial sequence homoplasmy and to slow mutation accumulation. The need for higher adaptive abilities enforced animals to allow higher mutation rates, and the detrimental consequences are counteracted by the mtDNA bottleneck and purifying selection. The result for the species is an optimal balance between negative deleterious mutations and positive adaptive mutations. As the bottleneck affects reproductive fitness, this is also a critical factor in this balance. The incorporation of repeat elements in the mtDNA of plants has enabled efficient recombinationmediated mtDNA repair in plant mtDNA, which results in low mitochondrial mutation rates. Fungi are described to have bottlenecks and restricted somatic fusions (Bastiaans et al., 2014) , whereas they simultaneously possess recombination-mediated mtDNA repair mechanisms (Aguileta et al., 2014) .
The role of mtDNA evolutionary mechanisms in fertility, disease and ageing
The way mitochondrial systems have evolved in animals and humans can have profound effects on healthy human reproduction. It affects the way mitochondrial diseases manifest and segregate (Shoubridge, 2001; Zeviani and Di Donato, 2004; Taylor and Turnbull, 2005) and it has consequences for mammalian fertility (Wai et al., 2010) , ageing, drug treatment (Kujoth et al., 2007) and reproductive options for patients.
Human mitochondrial diseases
Incomplete EGT and nuclear gene replacements (de Grey, 2005) have led to the existence of two genomes in a eukaryotic cell, and consequently to two genetically distinct types of mitochondrial diseases. Defects in the genes which have been transferred to the nuclear DNA lead to Mendelian diseases (Shoubridge, 2001 ), for example, in genes that control the stability of the mtDNA (such as POLG and Twinkle). Defects in the mtDNA genes (37, in mammals) cause maternally inherited or sporadic mitochondrial diseases (at a frequency of 1 in 10 000 individuals; Chinnery et al., 2012) and over 500 mtDNA point mutations have been identified (Ruiz-Pesini et al., 2007) . The bigenomic origin of mitochondrial proteins complicates the genetic diagnostics of mitochondrial diseases, which are clinically highly variable, and for which, in most cases, no clear genotype-phenotype correlations exist. Genome-wide diagnostic procedures, like mtDNA sequencing in combination with whole-exome sequencing are currently taking the stage. Without a diagnosis based on a confirmed genetic defect, genetic counselling is challenging, since the prognosis and recurrence risks are unclear (Vento and Pappa, 2013 ). An established genetic defect in either the mtDNA or in nuclear genes has profound consequences for the prognosis and transmission of the disorder and, consequently, for the reproductive choices that patients or carriers have. Prenatal diagnosis (PND) is the preferred option for prevention of the transmission of nuclear mutations, but for mitochondrial disorders caused by heteroplasmic mtDNA mutations, PND is often unreliable due to difficulty in predicting the clinical phenotype from the mutation load in chronic villus sampling or amniocytes. Two exceptions exist. First, mothers of patients with a de novo mutation, which is fairly common for mtDNA disorders (see below), have a very low recurrence risk and PND can be offered for reassurance. Secondly, carriers of low levels of mtDNA mutations that display skewing can be offered PND as it is likely that the interpretation of the mutation load is unambiguous (Poulton and Turnbull, 2000; Smeets, 2013) . Current alternatives for preventing the transmission of mtDNA disorders are oocyte donation and preimplantation genetic diagnosis (PGD). During PGD, oocytes are fertilized in vitro, biopsied at the blastomeric stage and only embryos with mutation below the threshold of clinical expression are transferred to the uterus (Sallevelt et al., 2013) . For most mtDNA mutations, insufficient data exist to define a mutation-specific threshold, but this has been overcome by a recent meta-analysis which showed a 95% or higher chance of being unaffected at a (muscle) mutant level of 18% or less, irrespective of the mutation (Hellebrekers et al., 2012; Sallevelt et al., 2013) . This opens up PGD for all heteroplasmic mtDNA mutation carriers that produce oocytes with mutation loads below this threshold. This is obviously not the case for homoplasmic mutations and for carriers with a very high mutation load of non-skewing mutations. A possible future reproductive option in mtDNA disorders is nuclear genome transfer (NGT), a procedure where the nuclear genome from an mtDNA mutation-harbouring zygote or oocyte is transferred to an enucleated acceptor harbouring mutation-free mtDNA (Craven et al., 2010) . This would be a solution for all mtDNA mutations, including the homoplasmic mutations. As a result, the offspring would be, apart from some carry-over, mtDNA mutation-free, while still harbouring the nuclear DNA from the mother. However, many technical, ethical and safety issues need to be addressed and settled, before NGT can be applied in clinic [see also (Craven et al., 2011; Smeets, 2013) ].
One aspect in this debate concerns the withdrawal of the mtDNA from its natural nuclear counterpart. It is a consequence of the two obligate genomes that OXPHOS integrity is governed by mitonuclear interactions and both genomes should match perfectly, requiring fast and efficient adaptations when variations arise in one of the genomes (Wolff et al., 2014) . The high mutation rates in the mtDNA force counter-adaptations in the nuclear genome that restore deleterious mutation consequences, as an evolutionary rescue (Dowling et al., 2008) . A certain level of mitonuclear variation is acceptable within populations, most likely to allow a certain degree of adaptation to environmental changes and allows long-term sustainability of our biodiversity when environmental circumstances change, creating new selection pressures (Wolff et al., 2014) , but disruption of mitonuclear interactions might result in adverse health outcomes (Reinhardt et al., 2013) or, in the long term, to reproductive isolation ultimately leading to allopatric speciation (Barreto and Burton, 2013) . Further evidence for an effect on fitness comes from D. melanogaster. When distinct naturally occurring mitochondrial genomes were placed against an isogenic nuclear background, gene expression was influenced by male-specific polymorphisms and led to male-specific modifications of nuclear gene expression ( 1500 genes), indicating a pervasive retrograde signalling between the genomes (Innocenti et al., 2011) . Other studies underline the role of mitonuclear interactions in determining key fitness traits and adverse health effects in other species (reviewed in Reinhardt et al., 2013) . Outcomes of these epistatic interactions also depend on the environment, indicating that mitonuclear interactions evolve in response to natural pressures on the population [reviewed in (Wolff et al., 2014) ]. Mitonuclear incompatibilities increase when the genetic distance becomes larger, e.g. when human cells lines are depleted of their mtDNA, repopulation with mtDNA of primates cannot restore the OXPHOS activity in these cells (Kenyon and Moraes, 1997) . Although no evidence exists for such a role of mitonuclear interactions in human outbred populations (Chinnery et al., 2014) , long-term implications have not been well studied and only address the paternal mitonuclear interactions (Reinhardt et al., 2013) . This is obviously a concern for NGT, as during NGT the maternal mitonuclear interaction is also disrupted, the impact of which is unknown. The only experimental evidence of four healthy macaques born after mitochondrial replacement seems reassuring (Tachibana et al., 2013) , but the consequences until the age of reproduction are not known and recent studies suggest that deleterious effects of mitonuclear incompatibilities will mainly manifest during adulthood (Reinhardt et al., 2013) .
Mitonuclear interactions can also be involved in the way either mtDNA mutations or nuclear genes manifest. The reduced penetrance of homoplasmic mutations in, for example, Leber's Hereditary Optic Neuropathy (LHON) and the sex differences could be explained by a role for the nuclear genome or the environment or both, although the full picture is not yet clear (Wolff et al., 2014) . Also, mtDNA variations can have a moderate effect on mitochondrial function, not leading to severe mitochondrial diseases, but contributing to the severity of other genetic or non-genetic disorders, where energy metabolism is a critical factor. In genetic disorders, mtDNA variants or haplogroups may rescue or deteriorate nuclear gene mutations, thereby modifying the severity of disease expression, as has been observed in cardiomyopathies (Strauss et al., 2013) . Further study is needed to elucidate the modifying effect of mitonuclear interactions in health and disease, which potentially adds to the complexity of mitochondrial diseases, but could also lead to disease prevention when epistatic relations can be matched (Moreno-Loshuertos et al., 2011) . A final observation with respect to mitonuclear interactions relates to the difference in the distribution of heteroplasmic mutations over singe cells (oocytes, fibroblasts, blastomeres), which can be random or skewed and which could be the result of a nuclear factor (Blok et al., 1997) . Evidence exists from mice studies, in which diverse patterns of segregation are observed among tissues, with tissue-specific selection for different mtDNA genotypes (Jenuth et al., 1997) , not caused by replication efficiency or differences in OXPHOS function (Battersby and Shoubridge, 2001) .
No effective therapy for mitochondrial disorders currently exists and new options are being explored. A dysfunctional OXPHOS system is often associated with an increased production of ROS (Vives-Bauza et al., 2006), for which existing rescue mechanisms fall short. In such cases, antioxidant supplementation could be used to ameliorate disease progress. Increased oxidative stress, however, appears to be mutationand patient-specific and fibroblasts of patients can be used to estimate the ROS damage and the potential benefit from antioxidant therapy (Voets et al., 2012) , although, at the same time, side-effects should be carefully evaluated (Bjelakovic et al., 2012) . As can be learned from plants, antioxidant systems can reduce mutation loads to a lower level than in animals. Therefore, using a heterologous gene, encoding a supplemental oxidase (e.g. AOX), otherwise absent from mammals, has been suggested as a possibility to neutralize increased ROS production by defective OXPHOS [reviewed in El-Khoury et al. (2014) ].
For nuclear genes, in some cases, treatments can be offered, based on the specific gene involved (Gerards, 2014) . Novel approaches are being developed to correct the more challenging mtDNA mutations, but gene correction or antigenomic (e.g. TALEN technology) approaches (reviewed in Russell and Turnbull, 2014) to target the mtDNA particularly suffer from an evolutionary drawback. Correcting the mtDNA requires correcting a multi-copy genome with a different code. Targeting the mitochondria is therefore quite cumbersome. An advantage is that it is not necessary to correct all the mtDNA copies, but it is sufficient to switch the balance to achieve a life-long effect. Promising results have been obtained in patient-derived cells, in which antigenomic mitoTALENs were capable of specifically eliminating mutant mitochondrial genomes (Bacman et al., 2013) . Alternative approaches that incorporate an mtDNA-encoded protein in the nuclear DNA require (1) correcting of the code (Nagley et al., 1988) , (2) adding an import sequence and (3) having the protein imported in the mitochondria. From an evolutionary perspective, this is very unlikely to be successful, as import of these proteins has not been possible ever in eukaryotic evolution and, with only few exceptions, the 13 protein-encoding genes in the mtDNA are conserved among all species, possibly due to high hydrophobicity, as has been demonstrated (Perales-Clemente et al., 2011).
MtDNA disease manifestation and transmission
De novo mutations
High mtDNA copy number together with high mutagenesis potential due to ROS can create heteroplasmic mutations not only in somatic cells, but also in germ cells. During mitochondrial inheritance, the high copy Evolutionary role of mtDNA in fertility and disease number of the oocyte is strongly reduced (Cree et al., 2008; Wai et al., 2008) , creating an increased risk for de novo mutations reaching functional significance and possible disease when pathogenic at the bottom of the bottleneck (Fig. 3) .
Lethal or severe de novo mtDNA disease
Given the variation in mtDNA content in oocytes and the constant timeframe of preimplantation development when no mtDNA replication occurs, it is likely that the mtDNA copy number at the bottom of the bottleneck can, in individual cases, be much lower than the mean of 200, increasing the risk that de novo mutations at this point reach very high levels, as has been observed for de novo mutations that reach homoplasmy (Degoul et al., 1997; Maassen et al., 2002; Burrage et al., 2014) . For a large part of patients with mtDNA diseases, the likely cause is a de novo mutation, although often this is based on the absence of a family history (Thorburn, 2004; Sallevelt et al., in preparation) and maternal material is needed to confirm whether these mutations are really de novo. The rate of de novo pathogenic mutations above the threshold of expression is somewhere below the minimal birth prevalence of 1 in 5000 found for mtDNA disease (Elliott et al., 2008) . The de novo pathogenic mtDNA mutations that reach high heteroplasmy levels will be subject to purifying selection (see below), and be embryonically lethal or manifest as severe, possibly fatal, disease in the offspring. As these children generally do not reproduce and the recurrence risk for the mother is very low, this will not lead to additional patients or familial disease.
Familial (de novo) mtDNA diseases
The evolutionary presence of transmittable pathogenic heteroplasmic mtDNA mutation in female carriers that are not subject to purifying selection creates a major burden of severe and unpredictable mtDNA diseases in their offspring and families (Fig. 3B) . Unaffected maternal relatives can be carriers as disease manifestations only occur above the threshold of expression and can only be identified by genetic testing. It is likely that these mutations have emerged at some moment in time as de novo mutations in germ cells at levels below the threshold of expression and were transmitted to the offspring with varying mutation loads. The frequency with which those mutations would occur de novo is difficult to assess and can only be addressed by random screening of newborns and matched maternal samples. One study (Elliott et al., 2008) indicated that 107 in 100 000 newborns harbour 1 of the 10 assessed, most prevalent mtDNA point mutations in their neonatal-cord blood, and these are not detected in the maternal blood, providing a rough, probably (under)estimated figure. Mutations found in a screen of human oocytes have supported this high frequency (Jacobs et al., 2007) .
Escaping the mtDNA bottleneck and purifying selection causes familial disease
As the mutations giving rise to lethal or severe disorders are transmitted at high mutation loads, this implies that purifying selection is not able to filter out all detrimental mutations, even though some of them have profound effects at the enzymatic and clinical level. For instance, the risk of having a child with fatal Leigh syndrome due to enzymatic deficiency of complex V caused by ATP6 mutations is higher when maternal mutation loads are high (Dahl et al., 2000) and no purifying selection occurs. It is known that some genes, such as ATP6, tolerate pathogenic mutations more, whereas other genes have a stronger signature of purifying selection, such as the highly conserved COX1 and COX2 genes (Stewart et al., 2008a, b) , implying a stronger evolutionary pressure, most likely at the level of the organelle. Transmitted pathogenic mutations remain as familial disease in society due to the variable expression (Taylor and Turnbull, 2005) . Furthermore, mutations in tRNA and rRNA genes are found at a much higher frequency than those in protein-encoding genes in the mtDNA mutator mice (Stewart et al., 2008a, b) , indicating a lower purifying pressure on these genes as well. This does not imply that those mutations are moderate at the clinical level, as many of them can lead to severe and often fatal disease [Leigh syndrome, Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS), Myoclonic Epilepsy with Ragged Red Fibers (MERRF)]. The distribution of tolerated functionally significant variants in genes coding for proteins is irreversibly correlated with the degree of conservation of the amino acid, although differences between genes exist, and variants are better tolerated in the loop and acceptor stem positions of tRNA genes (Voets et al., 2011) .
Why pathogenic mutations with a severe effect on OXPHOS function escape purifying selection at the level of the organelle is not clear. It could be the result of different mtDNA genomes complementing each other, masking the biochemical defect . This seems unlikely for the mutations reaching a very high embryonic mutation load as complementation would fall short in those cases. When the frequency of the heteroplasmy is low, selection is much weaker, indicating that purifying selection is too weak to remove low frequent pathogenic heteroplasmy (Ye et al., 2014) . The net result could be that low-frequency heteroplasmic mtDNA mutations with high pathogenic potential are present at high frequencies, potentially affecting offspring in future generations. The 10 most prevalent mtDNA mutations have a population frequency between 1 in 155 (Ye et al., 2014) and 1 in 200 (Elliott et al., 2008) , indicating an even larger pool of all pathogenic mtDNA mutations within a population, which can be due to de novo mutations (Elliott et al., 2008) and/or less-efficient purifying selection (Ye et al., 2014) . Dramatic changes in heteroplasmy can occur during transmission due to the mtDNA bottleneck (Brown et al., 2001) . This can be positively corroborated by a replication advantage of the mtDNA carrying the mutation or negatively corroborated by a replication disadvantage of a mitochondrion with reduced fitness.
The combined action of the mtDNA bottleneck, purifying selection (either on the level of the organelle or the phenotype) complementation and replicative differences is complex and a thorough understanding is lacking. The combined mechanisms induce a complex mtDNA disease inheritance (Fig. 3) , which is difficult to understand and predict and might be further influenced by the nuclear background. Comparison of the severe mutations that do and do not escape purifying selection at the level of the organelle as well as complementation and replication studies might shed further light on the underlying mechanisms involved, which could open up opportunities to prevent the more damaging mutations.
Fertility and viability
The mtDNA copy number is important for successful fertilization and embryogenesis and the oocyte mtDNA content should be sufficient for normal vertebrate development until implantation (Ebert et al., 1988) . The dependence of normal fertilization and reproduction on mitochondria is reflected by the large mtDNA content of fertilized oocytes compared with unfertilized oocytes (Santos et al., 2006) and is allowed due to clonal expansion of mtDNA during oogenesis.
Apparently oocytes with an insufficient mtDNA amount are prevented from being fertilized, as indicated by the low mtDNA count in degenerate oocytes (Santos et al., 2006) . In mice, it was shown that oocytes with only 4000 mtDNA copies can still be fertilized, but fail to develop after implantation and that at least 50 000 copies of mtDNA are needed in a mature oocyte to be able to resume development after implantation, Figure 3 Mitochondrial evolutionary mechanisms: implications for fertility, mtDNA disease risk and reproductive options. mtDNA is important for healthy human reproduction (A) and altered mitochondrial parameters can cause fertility problems and mtDNA diseases (B and C). The mitochondrial evolutionary systems determine the reproductive options patients have. (A) Owing to the bottleneck, a sufficient amount of mtDNA is necessary for healthy reproduction. Whenever mtDNA mutations (red circles) are present, these are filtered out by the purifying bottleneck during oogenesis, rendering only oocytes without mtDNA mutations (black circles). Even if de novo mutations occur during the bottleneck (red thunderbolt symbol), these mutations would be compensated by the high numbers of mtDNA molecules without mutations (all below disease threshold). (B) In case of a low mtDNA copy number, the risk is higher for de novo mutations to reach values above the disease threshold and affect the offspring. Usually, other oocytes are unaffected and recurrence risk is low. PND can be offered for reassurance. If the mtDNA amount in oocytes is too low, oocytes would be unable to implant (blue oocytes) or even to develop (red oocytes), according to the amount of mtDNA present. (C and D) Female carriers of (familial) mtDNA mutations generally produce oocytes with different mutation loads, leading either to healthy offspring (green oocytes) with a mutation load below level of expression or to affected offspring (grey oocytes). During PGD, the unaffected embryos can be selected. In some cases, all oocytes carry high mutation loads (D). In these patients, NGT can be a future option, in which the nucleus of the carrier oocytes is transferred to an enucleated acceptor oocyte with healthy mtDNA molecules.
Evolutionary role of mtDNA in fertility and disease which would lead to values of 1-2 and 22 at the bottom of the bottleneck ( Fig. 3 ; Wai et al., 2010) . Whether the required mtDNA levels are the same in humans is unclear, though a clear correlation has been observed between mtDNA content and fertilizability of oocytes. Oocytes with fertilization failure had 152 000 mtDNA molecules (Reynier et al., 2001) , while in ovarian insufficiency, the count of mtDNA is 100 000 (May-Panloup et al., 2005a, b) . A negative correlation between fertilizability and mtDNA count explains the reduced fertility of oocytes from older women, since increasing maternal age reduces the mtDNA levels in oocytes (de Boer et al., 1999) , as well as the developmental competence (Yamamoto et al., 2010) . This is corroborated by the observation that premature ovarian failure can be caused by dominant mutations in the replication domain of the POLG gene, causing mtDNA depletion (Pagnamenta et al., 2006) . In contrast, the high de novo mutation rate in humans suggests that a low mtDNA copy number at the bottom of the bottleneck could still be viable and able to develop after implantation. This might reflect the difference between rodent eccentric and human interstitial implantation (Wimsatt, 1975) , since a fast shift to the uterus for energy supply could indicate that oocytes with lower mtDNA count in humans are still able to implant and develop, but at the cost of a higher mutation risk. However, this hypothesis is speculative and lacks proper evidence and should be further studied to elucidate the de novo mutation risk.
An advantage of the reduced fertility associated with a low mtDNA copy number in oocytes is that this prevents fertilization of those oocytes which have the highest risk of de novo mtDNA mutations (Santos et al., 2006) . Nevertheless, a critical group of oocytes remains that still can be fertilized and will lead to viable offspring, but will have, as shown by the high de novo disease frequency, an increased risk for de novo mtDNA mutations that can reach high levels of heteroplasmy. If this indeed relates to the mtDNA copy number, then this would enable the identification of those women at risk of having severely affected children with de novo mtDNA disease. The frequency of mitochondrial disease does not justify a population-wide prenatal screening, but this might be different if a group of women with a high a priori risk could be identified. This should be elucidated by further studies on the relation between mtDNA copy number and de novo disease risk.
The role of mtDNA copy number in fertility would justify supplementation of mitochondria in oocytes by injection of cytoplasm or mitochondria from donor oocytes (ooplasm) to enhance fertilization outcomes. In bovines, ooplasm transfer was able to rescue developmentally compromised oocytes (by ethidium bromide exposure) and led to proper development (Chiaratti et al., 2011) . The first results in humans have been promising and suggest that fertilization outcomes could indeed be improved and as successful implantations were achieved (Barritt et al., 2001) , but concerns have arisen about the health consequences in the long term. Additionally, although the causality with observed chromosomal abnormalities has not been proved (Barritt et al., 2001) , it has led to a stop to human ooplasm transfer. Furthermore, ooplasm transfer results in sustained, possibly detrimental, mtDNA heteroplasmy from both donor and recipient (Brenner et al., 2000) . Although most current experimental animal models do not justify such concerns (Chiaratti et al., 2011) , one should be careful, especially in terms of possible mitonuclear disruptions, as described above, requiring studies on the (long-term) effects of ooplasm donation (St John, 2002) .
Although male fertility is still ensured even when mtDNA copy numbers are low, mitochondrial function does determine spermatazoan function (Ruiz-Pesini et al., 2000) . Energy for movement is thought to be mainly regulated by the mitochondrial sheath of spermatozoa (Rawe et al., 2007) and mitochondrial mutations can reduce sperm motility (Holyoake et al., 2001) . Although a low mtDNA content leads to low-quality sperm (Amaral et al., 2013) , sperm with abnormal semen parameters tends to have increased mtDNA contents with lower mtDNA integrity, most likely to compensate for the defects (Song and Lewis, 2008) . Especially, in those cases with asthenozoospermia (low sperm motility) caused by mitochondrial defects, intracytoplasmic sperm injection (ICSI) can be performed. During ICSI, a sperm cell is injected directly into the oocyte, and can overcome asthenozoospermic cases caused, for example, by a mitochondrial problem (Rawe et al., 2007) . The concern that paternal mtDNA could be sustained, whereas it is normally degraded (St John et al., 2000) has not been confirmed in ICSI follow-up studies and mice studies indicate that sperm mitochondria are also degraded after ICSI (Cummins et al., 1997; Danan et al., 1999) .
Human ageing
Widespread evidence exists for a role of mtDNA mutations in mammalian ageing (reviewed in Kujoth et al., 2007) , such as the premature ageing phenotype observed in mice that accumulate mtDNA mutations due to defects in POLG proofreading activity (Trifunovic et al., 2004) . This is in line with the mitochondrial free radical theory of ageing, in which ROS provokes accumulation of oxidative damage (e.g. mtDNA mutations) and subsequent disruption of cellular homeostasis, which is thought to be involved in ageing. However, a study in D. melanogaster indicated that ROS accumulation does not directly regulate lifespan, since increased or decreased ROS production did not change the lifespan accordingly (Sanz et al., 2010) , suggesting another mitochondrial parameter must be dictating the ageing process. In line with these observations, it was recently shown that the frequency of low-level mutations present at birth does not change significantly with age, implying no increased mtDNA mutation rate during ageing and that pathogenic mtDNA mutations that are already present early in life (before 20 years of age) cause the major disease burden. Indeed, as discussed above, although female germ cells are generally well preserved against mtDNA mutagenesis, the system is not perfect (e.g. de novo mutations, escaping selection) and low-level mtDNA heteroplasmy is common (Elliott et al., 2008; Payne et al., 2013; Ye et al., 2014) . Clonal expansion of these pre-existing mtDNA mutations occurs, which can lead to ageing due to mitochondrial dysfunction (e.g. COX deficiency) (Greaves et al., 2014) . A (new) mutation can reach homoplasmy in 70 generations of cell divisions (Ye et al., 2014) , which takes 40 years for post-mitotic tissues (Elson et al., 2001b) such as skeletal muscle and neurons. Somatic mtDNA mutations that contribute to ageing might originate after re-initiation of replication after embryo implantation (Shoubridge, 2000) , beyond the action of selective evolutionary processes (bottleneck and purifying selection) (Greaves et al., 2014) , but can also be inherited. This does not completely preclude a role for ROS production in the ageing process, since correlations between ROS and lifespan exist (Sanz et al., 2010) and the mutagenesis potential of ROS can induce point mutations during early life, as well as accelerate the accumulation of mutations. If clonal expansion of early mtDNA mutations is underlying ageing, mutations that originate de novo somatically later in life are no major contributors to ageing. In agreement with the clonal-expansion hypothesis, a clear relationship between antioxidant therapy supplementation and longevity is lacking (reviewed in Fusco et al., 2007) . Possibly, prevention of ROS-induced mutations early in life (,20 years of age) is more helpful, which might be achieved by antioxidants and dietary restriction. Dietary restriction has been shown to clearly increase lifespan when applied in several species, including rhesus monkeys (Colman et al., 2014) .
Interventions that reduce mtDNA copy number can induce a somatic bottleneck that can accelerate clonal expansion of point mutations leading to premature ageing or age-related mitochondrial disease, e.g. the mitotoxicity observed during HIV treatment with anti-retroviral drug administration in some patients (Payne et al., 2011) . Most likely, POLG and subsequently mtDNA replication can be inhibited by nucleotide-analogue reverse-transcriptase inhibitors (NRTIs) administered for HIV treatment, leading to mtDNA depletion (Gardner et al., 2013) and subsequent pathology due to the clonal expansion of preexisting age-related somatic mtDNA mutations (Payne et al., 2011) . Since POLG is of viral origin, this system can be vulnerable to medications that are supposed to target viral systems (Kohler and Lewis, 2007) .
Concluding remarks
The mitochondria with their own genome were indispensable for the success of eukaryotic development and the existence of complex, multicellular organisms, such as in the end human beings. However, every success has a price and in individual human beings, this price consists of mitochondrial and mtDNA-related diseases orders, infertility and (accelerated) ageing-related diseases. The consequences of mitochondrial evolution on fertility, reproduction and offspring are summarized in Fig. 3 . This review demonstrates that evolutionary studies contribute significantly to identify and understand the underlying mechanisms, which is of key importance for † designing successful gene replacement or antigenomic strategies to correct mtDNA defects; † identifying the risk of women having children with mtDNA diseases, in exploring the safety of innovative (reproductive) treatments, such as NGT which potentially disrupts the common, evolutionary important mitonuclear interactions in order to prevent transmission of mtDNA diseases; † options to treat mtDNA-related female infertility, which might have a similar drawback; † ameliorating mitochondrial disease by ROS protection; and † preventing or altering drug-or age-induced mtDNA-related pathology.
Theodosius Dobzhansky stated that 'Nothing in biology makes sense except in the light of evolution' and this seems particularly the case for genetics and reproduction.
